Nanomedicine prompts the development of CRISPR-Cas9 therapies to treat hereditary angioedema
The potential of non-viral lipid delivery systems for improving global health has been proven once again. From rare diseases to cancer, gene editing and gene therapies will undoubtedly benefit from the latest advances in nanomedicine. In February 2024, the results from a promising combined phase [...]
